Grants and Contributions:
Title:
Scalable Validation Framework for Multi-Objective AI-Driven Molecular Design for Drug Development
Agreement Number:
1041626
Agreement Value:
$60,000.00
Agreement Date:
Apr 1, 2026 - Mar 31, 2027
Description:
Thoth Biosimulations is developing a generative AI platform for multi-objective small molecule drug design. Firm intends to undertake R&D to validate model performance across competing objectives and to scale evaluation to large chemical spaces. This project will develop a robust benchmarking framework to evaluate trade-offs between drug design criteria and scalable pipelines for large-scale candidate evaluation, advancing AI-driven drug discovery in Canada.
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Edmonton, Alberta, CA T5J 4P6
Reference Number:
172-2026-2027-Q1-1041626
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
791707508
Recipient Type:
For-profit organization
Amendment Date
0001-01-01T00:00:00
Recipient's Legal Name:
Thoth BioSimulations Incorporated
Federal Riding Name:
Edmonton Centre
Federal Riding Number:
48014
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
541710
Amendments: